APA (7th ed.) Citation

MD, S., SM, V., MJ, E., EG, H., NS, M., FJ, B., & BC, F. (2011). Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: A meta-analysis. Human Reproduction Update, 17(2), 184.

Chicago Style (17th ed.) Citation

MD, Sterrenburg, Veltman-Verhulst SM, Eijkemans MJ, Hughes EG, Macklon NS, Broekmans FJ, and Fauser BC. "Clinical Outcomes in Relation to the Daily Dose of Recombinant Follicle-stimulating Hormone for Ovarian Stimulation in in Vitro Fertilization in Presumed Normal Responders Younger than 39 Years: A Meta-analysis." Human Reproduction Update 17, no. 2 (2011): 184.

MLA (9th ed.) Citation

MD, Sterrenburg, et al. "Clinical Outcomes in Relation to the Daily Dose of Recombinant Follicle-stimulating Hormone for Ovarian Stimulation in in Vitro Fertilization in Presumed Normal Responders Younger than 39 Years: A Meta-analysis." Human Reproduction Update, vol. 17, no. 2, 2011, p. 184.